Abstract:Objective To study the effects of low molecular weight heparin ( LMWH) on renal osteodystrophy and vascular calcification in rats with chronic kidney disease (CKD) in comparison with unfractionated heparin (UFH). Methods CKD model with secondary hyperparathyroidism was established by feeding adenine diet to rats. 50 male SD rats were randomly divided into five groups for six weeks' raising: (1) Normal group; (2) CKD group; (3) CKD unfractionated heparin (UFH) group (CKD heparin); (4) CKD low-dose LMWH group (CKD L-LMWH); (5) CKD high-dose LMWH group (CKD H-LMWH). The normal control group was fed with diet without adenine for 6 weeks and the other 4 groups were raised by adenine-containing diet for the first 4 weeks and diet without adenine for the following 2 weeks. Six weeks later, all rats were executed. Calcium and phosphorus contents of were tested using spectrum analysis and bone mineral density ( BMD) and biomechanical parameters were determined at femur and the 5thlumbar vertebra. Results There were no statistical differences on vascular calcium or phosphorus content between the CKD group, CKD heparin group, CKD L-LMWH group and CKD H-LMWH group. Compared with the CKD group, femur total and trabecular BMD and lumbar BMD were significantly lower in the CKD heparin group, but there were no significant differences between the CKD group, CKD L-LMWH group and CKD H-LMWH group in femur total and trabecular BMD and lumbar BMD. No significant differences were found in femur cortical BMD between the CKD group, CKD heparin group, CKD L-LMWH group and CKD H-LMWH group. In the lumbar compression test, the structural and material biomechanical parameters (maximum load, stiffness, maximum stress and elastic modulus) were significantly reduced in the CKD heparin group compared with the CKD group, and there were no significant differences between the CKD group, CKD L-LMWH group and CKD H-LMWH group on these lumbar biomechanical parameters. In the three-point bending test, no significant differences were found between the CKD group, CKD heparin group, CKD L-LMWH group and CKD H-LMWH group on the structural and material biomechanical parameters (maximum load, stiffness, maximum stress and elastic modulus). Conclusion LMWH had no effect on BMD and biomechanical parameters of trabecular bone in CKD rats with secondary hyperparathyroidism, and UFH could reduce BMD and biomechanical properties of trabecular bone in CKD rats with secondary hyperparathyroidism. Both LMWH and UFH had no significant effect on BMD and biomechanical parameters of cortical bone in CKD rats with secondary hyperparathyroidism. Both LMWH and UFH had no effect on vascular calcification in CKD rats with secondary hyperparathyroidism.

Experimental study of low molecular weight heparin on renal protection in diabetic rats

The Protective Effect of Low Molecular Weight Heparin on Early Nephropathy in Diabetic Rats

[Effects of Low Molecular Weight Heparin on Vascular Endothelial Growth Factor Expression of Early Diabetic Nephropathy].

Investigation of Inhibition of Thrombospondin-1 ( TSP-1 ) Expression by Puerarin in Kidney of Diabetic

The Renal Protective Effects of Cilostazol on Suppressing Pathogenic Thrombospondin-1 and Transforming Growth Factor-β Expression in Streptozotocin-Induced Diabetic Rats

A Low-Dose Combination of Valsartan and Low Molecular Weight Heparin Better Improved Glomerular Permeability Than Did High-Dose Monotherapy in Rats with Diabetic Nephropathy.

Influence of low-molecular-weight heparin on PAI-1 in rats with immune complexes nephritis

Research Progress of Low Molecular Weight Heparin

Influence of low molecular weight heparin on the lipometabolism in hemodialysis patients

Effects of Low Molecular Weight Heparin on Treatment of Nephrotic Syndrome

The effect of low molecular weight heparin as an antioxidant in chronic kidney disease

Protective effect of Valsartan on renal function of rats with diabetes mellitus

Protection of Liuwei Dihuang pill on diabetic nephropathy in rats

Low molecular weight heparin promotes the PPAR pathway by protecting the glycocalyx of cells to delay the progression of diabetic nephropathy

The Clinical Effect of Low Molecular Heparin on Maintenance of Hemodialysis

Protective Effect and Mechanism of Huanglian Jiedu Tang on Diabetic Nephropathy Rats

Protective Effect on Kidney and Mechanism of Chinese Medicinal with Actions of Replenishing Qi,nourishing Yin,removing Accumulation and Free Collateral Vessels in Rats with Early Diabetes

A comparative study on effects of low molecular weight heparin and unfractionated heparin on renal osteodystrophy and vascular calcification in rats with chronic kidney disease

Comparison of Renoprotective Effect of Dabigatran With Low-Molecular-Weight Heparin

Clinical observation of low molecular weight heparin on calcium-phosphate metabolism in maintenance hemodialysis patients

Protective and Therapy Effect of Compound Chinese Medicine Yiqi Jiedu Huoluo Fang in Rats with Diabetes Nephropathy